|
Volumn 17, Issue 7, 2009, Pages 505-508
|
[Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKALOID;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
MATRINE;
QUINOLIZINE DERIVATIVE;
VIRUS DNA;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
LIVER FAILURE;
LIVER FUNCTION TEST;
MALE;
MIDDLE AGED;
PATHOLOGY;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ALKALOIDS;
ANTIVIRAL AGENTS;
DNA, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
INTERFERON-ALPHA;
LAMIVUDINE;
LIVER FAILURE;
LIVER FUNCTION TESTS;
MALE;
MIDDLE AGED;
QUINOLIZINES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 77958181851
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|